Regulatory approval and reimbursement policies are key factors shaping the Ai assisted radiology market. Governments and health authorities are working to establish frameworks that ensure the safety and efficacy of AI applications in clinical settings.
In parallel, payers are beginning to recognize the value of AI in improving diagnostic outcomes and reducing healthcare costs. Favorable reimbursement policies incentivize healthcare providers to adopt AI technologies, thereby accelerating the market’s growth trajectory.
2 Views
